DDMM Heart Institute installs real-time cardiac view recognition ultrasound system: Our Bureau, Mumbai Thursday, June 26, ...

Aspire Biopharma enrolls last patient in phase 1 trial of its oral transmucosal fast-acting high-dose aspirin formulation: Estero, Florida Thursday, June 26, 2025, 18:00 Hrs [IST] ...

Our Bureau, Bengaluru Thursday, June 26, 2025, 14:15 Hrs [IST] ...

START Center for Cancer Research introduces a new digital patient & physician-focused platform for community-based cancer trials: San Antonio, Texas Thursday, June 26, 2025, 17:00 ...

Innovent Biologics presents results from DREAMS-1 phase 3 study of mazdutide in Chinese adults with T2D at ADA Scientific Sessions: San Francisco Thursday, June 26, 2025, 14:00 Hr ...

Kashmik Formulation to expand capacity, eyes Rs. 100 crore revenue in FY26: Our Bureau, Mumbai Thursday, June 26, 2025, 17:50 Hrs [IST] Kashmik Formulation, a pharmaceutical manuf ...

Evotec joins NURTuRE-AKI consortium to gain multi-omics-based molecular understanding of acute kidney injury: Hamburg, Germany Thursday, June 26, 2025, 11:00 Hrs [IST] Evotec SE, ...

Arlington Heights, Illinois Thursday, June 26, 2025, 13:00 Hrs [IST] ...

Bio-Thera Solutions & SteinCares expand partnership to commercialize biosimilars to treat inflammatory diseases across Latin America: Guangzhou, China Thursday, June 26, 2025, 12: ...

Global pharma major Lupin Limited (Lupin) announced the launch of prucalopride tablets, 1 mg, and 2 mg, in the United States, following the recent approval of its Abbreviated New Drug Application ...

Curiteva receives US FDA 510(k) clearance for its Inspire Trabecular PEEK Standalone ALIF system: Huntsville, Alabama Thursday, June 26, 2025, 16:00 Hrs [IST] Curiteva, a privatel ...

US FDA grants orphan drug designation to Sanofi’s riliprubart for antibody-mediated rejection in solid organ transplantation: Paris Thursday, June 26, 2025, 09:00 Hrs [IST] The ...